Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | |
---|---|---|---|---|---|---|---|---|---|
UNHUnitedHealth Group | US$391.01 | 3.9% | 34.6% | US$370.6b | US$410.65 | P/E21.9x | E1.8% | 1.3% | |
DHRDanaher | US$243.06 | 4.6% | 55.3% | US$178.3b | US$261.84 | P/E48.9x | E27.4% | 0.3% | |
NVCRNovoCure | US$192.50 | 45.7% | 165.7% | US$19.4b | US$187.50 | P/E980.9x | E-4.4% | n/a | |
ABTAbbott Laboratories | US$124.35 | 2.9% | 29.5% | US$222.8b | US$133.80 | P/E49.6x | E64.6% | 1.4% | |
MDTMedtronic | US$125.91 | 3.2% | 21.9% | US$169.1b | US$132.77 | P/E55.2x | E72.1% | 1.8% | |
BDXBecton Dickinson | US$260.94 | 5.2% | -0.2% | US$78.6b | US$282.20 | P/E49.1x | E58.8% | 1.3% | |
ANTMAnthem | US$375.62 | 4.0% | 40.3% | US$94.2b | US$380.55 | P/E20.6x | E28.1% | 1.2% | |
ISRGIntuitive Surgical | US$812.57 | 3.6% | 54.4% | US$95.1b | US$783.70 | P/E89.6x | E14.4% | n/a | |
IDXXIDEXX Laboratories | US$535.00 | 6.4% | 101.8% | US$45.7b | US$533.13 | P/E78.5x | E11.9% | n/a | |
CVSCVS Health | US$75.88 | 2.4% | 19.8% | US$99.2b | US$87.67 | P/E13.8x | E13.2% | 2.6% | |
HUMHumana | US$435.28 | 4.2% | 16.5% | US$57.5b | US$474.05 | P/E17.1x | E-18.6% | 0.6% | |
BSXBoston Scientific | US$40.91 | 4.0% | 6.8% | US$41.3b | US$43.24 | P/S5.8x | S8.7% | n/a | |
CICigna | US$252.57 | 2.6% | 30.1% | US$92.2b | US$268.43 | P/E10.9x | E-36.3% | 1.6% | |
HCAHCA Healthcare | US$196.93 | 3.2% | 70.3% | US$66.6b | US$200.00 | P/E17.7x | E14.5% | 1.0% | |
EWEdwards Lifesciences | US$89.02 | 3.5% | 16.9% | US$55.4b | US$93.95 | P/E67.3x | E43.8% | n/a | |
DXCMDexCom | US$400.04 | 4.5% | 23.7% | US$37.8b | US$452.56 | P/E76.5x | E-54.7% | n/a | |
SYKStryker | US$257.13 | 1.5% | 35.7% | US$96.6b | US$252.84 | P/E60.4x | E61.5% | 1.0% | |
CNCCentene | US$64.96 | 3.8% | -8.9% | US$37.1b | US$80.53 | P/E20.5x | E30.0% | n/a | |
TDOCTeladoc Health | US$190.10 | 4.9% | 9.7% | US$17.2b | US$256.72 | P/S15.7x | E48.8% | n/a | |
VEEVVeeva Systems | US$273.07 | 3.3% | 50.8% | US$41.1b | US$325.09 | P/E108.3x | E6.6% | n/a | |
WSTWest Pharmaceutical Services | US$313.83 | 5.8% | 84.6% | US$23.2b | US$309.17 | P/E67x | E31.9% | 0.2% | |
RMDResMed | US$207.51 | 4.2% | 25.6% | US$30.1b | US$200.36 | P/E43x | E6.2% | 0.8% | |
ALGNAlign Technology | US$606.33 | 2.3% | 214.2% | US$47.8b | US$587.27 | P/E26.9x | E-65.2% | n/a | |
BAXBaxter International | US$86.56 | 1.9% | -6.9% | US$44.1b | US$91.11 | P/E40x | E47.6% | 1.1% |